Nicotine Discrimination in Humans

Drug Discrimination: Applications to Medicinal Chemistry and Drug Studies

Volumn , Issue , 2011, Pages 463-481

  Perkins, Kenneth A ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Discrimination sensitivity difference; Discrimination threshold dose; Nicotine discrimination

Indexed keywords

EID: 84886066183     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781118023150.ch15     Document Type: Chapter

References (61)

1. Rose, J.E., Corrigall, W.A. ( 1997 ). Nicotine self - administration in animals and humans: similarities and differences . Psychopharmacology, 130, 28-44.
2. Stolerman, I.P., Jarvis, M.J. ( 1995 ). The scientific case that nicotine is addictive. Psychopharmacology, 117, 2-10.
3. Fischman, M.W., Foltin, R.W. ( 1991 ). Utility of subjective-effects measurements in assessing abuse liability of drugs in humans. British Journal of Addiction, 86, 1563-1570.
4. Perkins, K.A. ( 1999 ). Baseline-dependency of nicotine effects: a review. Behavioural Pharmacology, 10, 597-615.
5. Preston, K.L., Bigelow, G.E. ( 1991 ). Subjective and discriminative effects of drugs. Behavioural Pharmacology, 2, 293-313.
6. Perkins, K.A., Sayette, M., Conklin, C.A., Caggiula, A.R. ( 2003 ). Placebo effects of tobacco smoking and other nicotine intake. Nicotine and Tobacco Research, 5, 695-709.
7. Stolerman, I.P. ( 1999 ). Inter-species consistency in the behavioural pharmacology of nicotine dependence. Behavioural Pharmacology, 10, 559-580.
8. Johanson, C.E. ( 1991 ). Discriminative stimulus effects of psychomotor stimulants and benzodiazepines in humans. In: R.A. Glennon, et al., Eds. Drug Discrimination: Applications to Drug Abuse Research. NIDA Research Monograph 116, pp 181-196.
9. Perkins, K.A., Sanders, M., Fonte, C., Wilson, A.S., White, W., Stiller, R., McNamara, D. ( 1999 ). Effects of central and peripheral nicotinic blockade on human nicotine discrimination. Psychopharmacology, 142, 158-164.
10. Bickel, W.K., Oliveto, A.H., Kamien, J.B., Higgins, S.T., Hughes, J.R. ( 1993 ). A novel-response procedure enhances the selectivity and sensitivity of a triazolam discrimination in humans. Journal of Pharmacology and Experimental Therapeutics, 264, 360-367.
11. Preston, K.L., Bigelow, G.E. ( 1998 ). Opioid discrimination in humans: discriminative and subjective effects of progressively lower training dose. Behavioural Pharmacology, 9, 533-543.
12. Overton, D.A. ( 1991 ). A historical perspective on drug discrimination. In: R.A. Glennon, T.U.C. Jarbe, J. Frankenheim, Eds. Drug Discrimination: Applications to Drug Abuse Research. NIDA Research Monograph 116. U.S. Government Printing Office, Washington DC, pp 5-24.
13. U.S. Department of Health and Human Services (USDHHS) ( 1988 ) The Health Consequences of Smoking: Nicotine Addiction. A Report of the U. S. Surgeon General. U.S. Public Health Service, Washington, DC.
14. Pomerleau, O.F., Pomerleau, C.S., Rose, J.E. ( 1989 ). Controlled dosing of nicotine: a review of problems and progress. Annals of Behavioral Medicine, 11, 158-163.
15. Hammond, D., Fong, G.T., Cummings, K.M., Hyland, A. ( 2005 ). Smoking topography, brand switching, and nicotine delivery: results from an in vivo study. Cancer Epidemiology Biomarkers & Prevention, 14, 1370-1375.
16. Hoffmann, D., Hoffman, I. ( 1997 ). The changing cigarette, 1950-1995. Journal of Toxicology and Environmental Health, 50, 307-364.
17. Kallman, W.M., Kallman, M.J., Harry, G.J., Woodson, P.P., Rosecrans, J.A. ( 1982 ). Nicotine as a discriminative stimulus in human subjects. In: F.C. Colpaert, J.L. Slangen, Eds. Drug Discrimination: Applications in CNS Pharmacology. Elsevier Biomedical Press, Amsterdam, pp 211-218.
18. Rose, J.E. ( 1984 ). Discriminability of nicotine in tobacco smoke: implications for titration. Addictive Behaviors, 9, 189-193.
19. Henningfield, J.E., Keenan, R. ( 1993 ). Nicotine delivery kinetics and abuse liability. Journal of Consulting and Clinical Psychology, 61, 743-750.
20. Perkins, K.A., Lerman, C., Keenan, J., Fonte, C., & Coddington, S. ( 2004 ). Rate of nicotine onset from NRT and acute responses in smokers. Nicotine and Tobacco Research, 6, 501-507.
21. Benowitz, N.L., Zevin, S., Jacob, P., III ( 1997 ). Sources of variability in nicotine and cotinine levels with use of nicotine nasal spray, transdermal nicotine, and cigarette smoking. British Journal of Clinical Pharmacology, 43, 259-267.
22. Craft, R.M., Howard, J.L. ( 1988 ). Cue properties of oral and transdermal nicotine in the rat. Psychopharmacology (Berl) 96: 281-284.
23. Jones, H.E., Garrett, B.E., Griffiths, R.R. ( 1999 ). Subjective and physiological effects of intravenous nicotine and cocaine in cigarette smoking cocaine abusers. Journal of Pharmacology and Experimental Therapeutics, 288, 188-197.
24. Perkins, K.A., Epstein, L.H., Stiller, R., Jennings, J.R., Christiansen, C., McCarthy, T. ( 1986 ). An aerosol spray alternative to cigarette smoking in the study of the behavioral and physiological effects of nicotine. Behavior Research Methods Instruments and Computers, 18, 420-426.
25. Schneider, N.G., Lunell, E., Olmstead, R.E., Fagerstrom, K.-O. ( 1996 ). Clinical pharmacokinetics of nasal nicotine delivery-a review and comparison to other nicotine systems. Clinical Pharmacokinetics, 31, 65-80.
26. Perkins, K.A., DiMarco, A., Grobe, J.E., Scierka, A., Stiller, R.L. ( 1994 ). Nicotine discrimination in male and female smokers. Psychopharmacology, 116, 407-413.
27. Gourlay, S.G., Benowitz, N.L. ( 1997 ). Arteriovenous differences in plasma concentration of nicotine and catecholamines and related cardiovascular effects after smoking, nicotine nasal spray, and intravenous nicotine. Clinical Pharmacology and Therapeutics, 62, 453-463.
28. Perkins, K.A., Sexton, J.E., Reynolds, W.A., Grobe, J.E., Fonte, C., Stiller, R.L. ( 1994 ). Comparison of acute subjective and heart rate effects of nicotine intake via tobacco smoking vs. nasal spray. Pharmacology, Biochemistry, and Behavior, 47, 295-299.
29. Preston, K.L. ( 1991 ) Drug discrimination methods in human drug abuse liability evaluations. British Journal of Addiction, 86, 1587-1594.
30. Perkins, K.A. ( 1999 ). Nicotine discrimination in men and women. Pharmacology, Biochemistry, and Behavior, 64, 295-299.
31. Perkins, K.A., D'Amico, D., Sanders, M., Grobe, J.E., Scierka, A., Stiller, R.L. ( 1996 ) Influence of training dose on nicotine discrimination in humans. Psychopharmacology, 126, 132-139.
32. Perkins, K.A., Sanders, M., D'Amico, D., Wilson, A. ( 1997 ). Nicotine discrimination and self-administration as a function of smoking status. Psychopharmacology, 131, 361-370.
33. Perkins, K.A., Gerlach, D., Broge, M., Sanders, M., Grobe, J.E., Fonte, C., Cherry, C., Wilson, A., Jacob, R. ( 2001 ). Quitting smoking produces minimal loss of chronic tolerance to nicotine. Psychopharmacology, 158, 7-17.
34. Benowitz, N.L., Henningfield, J.E. ( 1994 ). Establishing a nicotine threshold for addiction. New England Journal of Medicine, 331, 123-125.
35. Perkins, K.A., Fonte, C., Sanders, M., Meeker, J., Wilson, A. ( 2001 ). Threshold doses for nicotine discrimination in smokers and nonsmokers. Psychopharmacology, 155, 163-170.
36. Smith, J.W., Stolerman, I.P. ( 2009 ). Recognising nicotine: the neurobiological basis of nicotine discrimination. In: J.E. Henningfield, E. London, S. Pogun, Eds. Nicotine Psychopharmacology. Springer, New York, pp 295-333.
37. Gonzales, D., Rennard, S.I., Nides, M., Oncken, C., Azoulay, S., Billing, C.B., Watsky, E.J., Gong, J., Williams, K.E., Reeves, K.R. ( 2006 ). Varenicline, an a4b2 nicotinic acetylcholine receptor partial agonist, vs. sustained-release bupropion and placebo for smoking cessation. Journal of the American Medical Assocation, 296, 47-55.
38. Smith, J.W., Mogg, A., Tafi, E., Peacey, E., Pullar, I.A., Szekeres, P., Tricklebank, M. ( 2007 ). Ligands selective for α4β2 but not α3β4 or a 7 nicotinic receptors generalise to the nicotine discriminative stimulus in the rat. Psychopharmacology, 190, 157-170.
39. Picciotto, M.R., Caldarone, B.J., King, S.L., Zachariou, V. ( 2000 ). Nicotinic receptors in the brain: links between molecular biology and behavior. Neuropsychopharmacology, 22, 451-465.
40. Perkins, K.A. ( 2009 ). Sex differences in nicotine reinforcement and reward: influences on the persistence of tobacco smoking. In: R. Bevins, A.R. Caggiula, Eds. The Motivational Impact of Nicotine and its Role in Tobacco Use. Springer-Verlag, New York, pp 143-169.
41. Quarta, D., Naylor, C.G., Barik, J., Fernandes, C., Wonnacott, S., Stolerman, I.P. ( 2009 ). Drug discrimination and neurochemical studies in alpha7 null mutant mice: tests for the role of nicotinic alpha7 receptors in dopamine release. Psychopharmacology (Berl), 203, 399-410.
42. Ray, R., Jepson, C., Patterson, F., Strasser, A.A., Rukstalis, M., Perkins, K.A., Lynch, K., O'Malley, S., Berrettini, W., Lerman, C. ( 2006 ). Association of OPRM1 Asn40Asp variant with the relative reinforcing value of nicotine in female smokers. Psychopharmacology, 188, 355-363.
43. Perkins, K.A., Lerman, C., Coddington, S.B., Jetton, C., Karelitz, J.L., Wilson, A.S., Jennings, J.R., Ferrell, R., Bergen, A.W., Benowitz, N.L. ( 2008 ). Gene and gene by sex associations with initial nicotine sensitivity in nonsmokers. Behavioural Pharmacology, 19, 630-640.
44. Kreek, M.J., Nielsen, D.A., Butelman, E.R., LaForge, K.S. ( 2005 ). Genetic influences on impulsivity, risk taking, stress responsivity and vulnerability to drug abuse and addiction. Nature Neuroscience, 8, 1450-1457.
45. Perkins, K.A., Lerman, C., Coddington, S.B., Jetton, C., Karelitz, J.L., Scott, J., Wilson, A.S. ( 2008 ). Initial nicotine sensitivity in humans as a function of impulsivity. Psychopharmacology, 200, 529-544.
46. Perkins, K.A., Gerlach, D., Broge, M., Grobe, J.E., Wilson, A. ( 2000 ). Greater sensitivity to subjective effects of nicotine in nonsmokers high in sensation-seeking. Experimental and Clinical Psychopharmacology, 8, 462-471.
47. Perkins, K.A. ( 2002 ). Chronic tolerance to nicotine in humans and its relationship to tobacco dependence. Nicotine and Tobacco Research, 4, 405-422.
48. Barrett, S.P., Boileau, I., Okker, J., Pihl, R.O., Dagher, A. ( 2004 ). The hedonic response to cigarette smoking is proportional to dopamine release in the human striatum as measured by positron emission tomography and [1 1C ] raclopride. Synapse, 54, 65-71.
49. Stolerman, I.P., Garcha, H.S., Pratt, J.A., Kumar, R. ( 1984 ). Role of training dose in discrimination of nicotine and related compounds by rats. Psychopharmacology, 84, 413-419.
50. Perkins, K.A., Fonte, C., Sanders, M., White, W., Wilson, A.S. ( 1999 ). Effects of training dose and two-versus three-choice testing procedure on nicotine discrimination responding in humans. Psychopharmacology, 145, 418-425.
51. Smith, B.J., Bickel, W.K. ( 1999 ). The novel-response procedure in humans. Pharmacology, Biochemistry, and Behavior, 64, 245-250.
52. Dani, J.A., Harris, R.A. ( 2005 ). Nicotine addiction and comorbidity with alcohol abuse and mental illness. Nature Neuroscience, 8, 1465-1470.
53. Mitchell, S.H., de Wit, H., Zacny, J.P. ( 1995 ). Effects of varying ethanol dose on cigarette consumption in healthy normal volunteers. Behavioural Pharmacology, 6, 359-365.
54. Lane, J.D. ( 1996 ). Association of coffee drinking with cigarette smoking in the natural environment. Experimental and Clinical Psychopharmacology, 4, 409-412.
55. Perkins, K.A., Fonte, C., Blakesley-Ball, R., Stolinski, A., Wilson, A.S. ( 2005 ). The influence of alcohol pre-treatment on the discriminative stimulus, subjective, and relative reinforcing effects of nicotine. Behavioural Pharmacology, 16, 521-529.
56. LeFoll, B., Goldberg, S.R. ( 2005 ). Ethanol does not affect discriminative stimulus effects of nicotine in rats. European Journal of Pharmacology, 519, 96-102.
57. Perkins, K.A., Fonte, C., Stolinski, A., Blakesley-Ball, R., Wilson, A.S. ( 2005 ). The influence of caffeine on nicotine's discriminative stimulus, subjective, and reinforcing effects. Experimental and Clinical Psychopharmacology, 13, 275-281.
58. Duka, T., Tasker, R., Russell, K., and Stephens, D.N. ( 1998 ). Discriminative stimulus properties of nicotine at low doses: the effects of caffeine preload. Behavioural Pharmacology, 9, 219-229.
59. Rose, J.E. ( 2006). Nicotine and non- nicotine factors in cigarette addiction. Psychopharmacology 184, 274-285.
60. Perkins, K.A., Ciccocioppo, M., Conklin, C., Milanak, M., Grottenthaler, A., Sayette, M. ( 2008 ). Mood influences on acute smoking responses are independent of nicotine intake and dose expectancy. Journal of Abnormal Psychology, 117, 79-93.
61. Young, R., Glennon, R.A. ( 2002 ). Nicotine and bupropion share a similar discriminative stimulus effect. European Journal of Pharmacology, 443, 113-118.